Continuous glucose monitoring reveals abnormal features of postprandial glycemic excursions in women with polycystic ovarian syndrome

Postgraduate Medicine

Volumn 123, Issue 2, 2011, Pages 185-190

  Tao, Minfang ^a   Zhou, Jian ^a   Zhu, Jieping ^a   Lu, Wei ^a   Jia, Weiping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Continuous glucose monitoring; Diabetes; Glucose excursion; Polycystic ovarian syndrome

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BIOLOGICAL PHENOMENA AND FUNCTIONS; BLOOD GLUCOSE MONITORING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTINUOUS GLUCOSE MONITORING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; METABOLIC PARAMETERS; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; POSTPRANDIAL GLYCEMIC EXCURSION; SENSITIVITY AND SPECIFICITY;

BLOOD GLUCOSE; CASE-CONTROL STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MONITORING, PHYSIOLOGIC; POLYCYSTIC OVARY SYNDROME; POSTPRANDIAL PERIOD; YOUNG ADULT;

EID: 79955125459     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2011.03.2277     Document Type: Article

References (28)

1. Sartor BM, Dickey RP. Polycystic ovarian syndrome and the metabolic syndrome. Am J Med Sci. 2005;330:336-342.
2. Barber TM, McCarthy MI, Franks S, Wass JA. Metabolic syndrome in polycystic ovary syndrome. Endokrynol Pol. 2007;58:34-41.
3. Pasquali R, Patton L, Pagotto U, Gambineri A. Metabolic alterations and cardiovascular risk factors in the polycystic ovary syndrome. Minerva Ginecol. 2005;57:79-85.
4. Essah PA, Nestler JE. The metabolic syndrome in polycystic ovary syndrome. J Endocrinol Invest. 2006;29(3):270-280.
5. Espinós-Gómez JJ, Corcoy R, Calaf J. Prevalence and predictors of abnormal glucose metabolism in Mediterranean women with polycystic ovary syndrome. Gynecol Endocrinol. 2009;25(3):199-204.
6. Chen X, Yang D, Li L, Feng S, Wang L. Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome. Hum Reprod. 2006;21:2027-2032.
7. De Leo V, Musacchio MC, Morgante G, La Marca A, Petraglia F. Polycystic ovary syndrome and type 2 diabetes mellitus. Minerva Ginecol. 2004;56(1):53-62.
8. Lo JC, Feigenbaum SL, Escobar GJ, Yang J, Crites YM, Ferrara A. Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: a population-based study. Diabetes Care. 2006;29(8):1915-1917.
9. Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12(6):673-668.
10. Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Neuro Endocrinol Lett. 2007;28(6):807-810.
11. Hu W, Hu WH, Qiao J, Wang LN, Zhao CY. Characteristics of abnormal glucose tolerance in patients with polycystic ovary syndrome. Zhonghua Yi Xue Za Zhi. 2009;89:2053-2055.
12. Barcellos CR, Rocha MP, Hayashida SA, Nery M, Marcondes JA. Prevalence of abnormalities of glucose metabolism in patients with polycystic ovary syndrome. Arq Bras Endocrinol Metabol. 2007;5:601-605.
13. Hirsch IB, Armstrong D, Bergenstal RM, et al. Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM). Diabetes Technol Ther. 2008;10:232-244.
14. Mazze RS, Strock E, Wesley D, et al. Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. Diabetes Technol Ther. 2008;10:149-159.
15. American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes Care. 2009;32(suppl 1):S13-S61.
16. Chen C, Lu FC; Department of Disease Control Ministry of Health, PR China. ILSI Focal Point in China. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17 suppl:1-36.
17. Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi. 2007;35:390-419.
18. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, 1999.
19. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41-47.
20. Zhou J, Jia WP, Yu M, et al. The reference values of glycemic parameters for continuous glucose monitoring and its clinical application. Zhonghua Nei Ke Za Zhi. 2007;46(3):189-192.
21. Zhou J, Jia W, Bao Y, Ma X, et al. Glycemic variability and its responses to intensive insulin treatment in newly diagnosed type 2 diabetes. Med Sci Monit. 2008;14:CR552-558.
22. Zhou J, Li H, Ran X, et al. Reference values for continuous glucose monitoring in Chinese subjects. Diabetes Care. 2009;32(7):1188-1193.
23. Rodbard D. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther. 2009;11:S55-S67.
24. Monnier L, Colette C, Owens DR. Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol. 2008;2(6):1094-1100.
25. Monnier L, Colette C, Owens DR. Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept. Diabetes Metab Res Rev. 2009; 25(5):393-402.
26. Ceriello A, Colagiuri S. International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations. Endocrinol Metab. 2008;21:109-116.
27. American Diabetes Association. Postprandial blood glucose. Diabetes Care. 2001;24:775-778.
28. Monnier L, Colette C, Dunseath GJ, Owens DR. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care. 2007;30(2):263-269.